Stay updated on ORION-01 Oregovomab & Nivolumab Clinical Trial
Sign up to get notified when there's something new on the ORION-01 Oregovomab & Nivolumab Clinical Trial page.

Latest updates to the ORION-01 Oregovomab & Nivolumab Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedMajor update: version bumped to v3.2.0 with a prominent notice about funding-related access limits and where to check current operating status; previously listed v3.1.0 has been removed.SummaryDifference2%

- Check29 days agoChange DetectedCore content update: version bumped from v3.0.2 to v3.1.0; no other substantive changes indicated.SummaryDifference0.1%

- Check43 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the old revision tag has been removed. The removal of 'Back to Top' is a minor UI change; overall, this is a straightforward release update with no substantive content changes.SummaryDifference0.1%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check58 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various proteins and antibodies related to malignant epithelial tumors of the ovary. Notably, the previous mentions of ovarian cancer and related antineoplastic agents have been removed.SummaryDifference2%

- Check72 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to ORION-01 Oregovomab & Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ORION-01 Oregovomab & Nivolumab Clinical Trial page.